Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Glioma × Biopsy × Clear all

Phase

Status

Active not recruiting 6 Recruiting 3 Completed 3 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Melanoma 6 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Mouth Neoplasms 4 Colorectal Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Neoplasms 3 Head and Neck Neoplasms 3 Uterine Cervical Dysplasia 2 Skin Neoplasms 2 Sarcoma, Kaposi 2 Sarcoma 2 Oropharyngeal Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Inflammatory Breast Neoplasms 2 HIV Infections 2 Colonic Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Turcot syndrome 1 Thrombocytosis 1 Squamous Intraepithelial Lesions 1

Interventions

Temozolomide 21 Bevacizumab 10 Radiotherapy 5 Irinotecan 5 Carmustine 4 Topotecan 3 Magnetic Resonance Spectroscopy 3 Magnetic Resonance Imaging 3 Carboplatin 3 Aminolevulinic Acid 3 ribociclib 2 poly ICLC 2 fluoromisonidazole 2 fluorodopa F 18 2 carmustine, poliferprosan 20 drug combination 2 cabozantinib 2 TIC10 compound 2 Surgical Procedures, Operative 2 Standard of Care 2 Re-Irradiation 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Panobinostat 2 O(6)-benzylguanine 2 Melphalan 2 Lomustine 2 Lacosamide 2 Filgrastim 2 Erlotinib Hydrochloride 2 Dynamic Contrast Enhanced Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04556929 2024-03-22

EDGE

University of Oxford

Phase NA Terminated

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡